SOMANYCERA.BO(SOMANYCERA.BO)
SOMANYCERA.BO
No analyst ratings available
No analyst price targets available for SOMANYCERA.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $31.23B | $33.66B | $35.77B |
| Low | $30.63B | $30.48B | $33.72B |
| High | $31.86B | $35.54B | $37.14B |
| EBITDA Avg | $2.91B | $3.14B | $3.33B |
| Low | $2.85B | $2.84B | $3.14B |
| High | $2.97B | $3.31B | $3.46B |
| EBIT Avg | $1.92B | $2.07B | $2.20B |
| Low | $1.88B | $1.87B | $2.07B |
| High | $1.96B | $2.18B | $2.28B |
| Net Income Avg | $1.11B | $1.37B | $1.69B |
| Low | $919M | $826M | $1.56B |
| High | $1.27B | $1.84B | $1.77B |
| EPS Avg | $27.11 | $33.32 | $41.13 |
| Low | $22.37 | $20.11 | $38.06 |
| High | $30.81 | $44.67 | $43.17 |
| Analysts (Rev / EPS) | 11 / 11 | 15 / 15 | 10 / 9 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $8.03B | $7.87B | $7.97B |
| Low | $8.03B | $7.87B | $7.97B |
| High | $8.03B | $7.87B | $7.97B |
| EBITDA Avg | $748M | $733M | $742M |
| Low | $748M | $733M | $742M |
| High | $748M | $733M | $742M |
| EBIT Avg | $493M | $483M | $489M |
| Low | $493M | $483M | $489M |
| High | $493M | $483M | $489M |
| Net Income Avg | $292M | $193M | $255M |
| Low | $292M | $193M | $255M |
| High | $292M | $193M | $255M |
| EPS Avg | $7.10 | $4.70 | $6.20 |
| Low | $7.10 | $4.70 | $6.20 |
| High | $7.10 | $4.70 | $6.20 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |